• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

miR-20a和miR-20b的差异分布可能是乳腺癌转移异质性的基础。

Differential distribution of miR-20a and miR-20b may underly metastatic heterogeneity of breast cancers.

作者信息

Li Jian-Yi, Zhang Yang, Zhang Wen-Hai, Jia Shi, Kang Ye, Zhu Xiao-Yu

机构信息

Department of Breast Surgery, Shengjing Hospital of China Medical University, Shenyang, Liaoning Province, China.

出版信息

Asian Pac J Cancer Prev. 2012;13(5):1901-6. doi: 10.7314/apjcp.2012.13.5.1901.

DOI:10.7314/apjcp.2012.13.5.1901
PMID:22901144
Abstract

BACKGROUND

The discovery that microRNA (miRNA) regulates metastasis provide a principal molecular basis for tumor heterogeneity. A characteristic of solid tumors is their heterogenous distribution of blood vessels, with significant hypoxia occurring in regions (centers of tumor) of low blood flow. It is necessary to discover the mechanism of breast cancer metastasis in relation to the fact that there is a differential distribution of crucial microRNA in tumors from centers to edges.

METHODS

Breast tissues from 48 patients (32 patients with breast cancer) were classified into the high invasive and metastatic group (HIMG), low invasive and metastatic group (LIMG), and normal group. Samples were collected from both the centers and edges of all tumors. The first six specimens were detected by microRNA array, and the second ten specimens were detected by real-time qRT- PCR and Western blot analyses. Correlation analysis was performed between the miRNAs and target proteins.

RESULTS

The relative content of miR-20a and miR-20b was lower in the center of the tumor than at the edge in the LIMG, lower at the edge of the tumor than in the center in the HIMG, and lower in breast cancer tissues than in normal tissues. VEGF-A and HIF-1alpha mRNA levels were higher in the HIMG than in the LIMG, and levels were higher in both groups than in the normal group; there was no difference in mRNA levels between the edge and center of the tumor. VEGF-A and HIF-1alpha protein levels were higher in the HIMG than in the LIMG, and protein levels in both groups were higher than in the normal group; there was a significant difference in protein expression between the edge and center of the tumor. Correlation analysis showed that the key miRNAs (miR-20a and miR-20b) negatively correlated with the target proteins (VEGF-A and HIF-1alpha).

CONCLUSIONS

Our data suggest that miR-20a and miR-20b are differentially distributed in breast cancer, while VEGF-A and HIF-1alpha mRNA had coincident distributions, and VEGF-A and HIF-1alpha proteins had uneven and opposing distributions to the miRNAs. It appears that one of the most important facets underlying metastatic heterogeneity is the differential distribution of miR-20a and miR-20b and their regulation of target proteins.

摘要

背景

微小RNA(miRNA)调控转移的发现为肿瘤异质性提供了主要分子基础。实体瘤的一个特征是其血管分布不均,在低血流区域(肿瘤中心)会出现明显的缺氧。鉴于关键微小RNA在肿瘤中心到边缘存在差异分布,有必要探寻其与乳腺癌转移相关的机制。

方法

将48例患者(32例乳腺癌患者)的乳腺组织分为高侵袭转移组(HIMG)、低侵袭转移组(LIMG)和正常组。从所有肿瘤的中心和边缘采集样本。前六个样本通过微小RNA芯片检测,后十个样本通过实时定量逆转录-聚合酶链反应(qRT-PCR)和蛋白质免疫印迹分析进行检测。对miRNA与靶蛋白进行相关性分析。

结果

在LIMG中,肿瘤中心的miR-20a和miR-20b相对含量低于边缘;在HIMG中,肿瘤边缘的miR-20a和miR-20b相对含量低于中心;在乳腺癌组织中的miR-20a和miR-20b相对含量低于正常组织。HIMG中VEGF-A和HIF-1α mRNA水平高于LIMG,两组均高于正常组;肿瘤边缘和中心的mRNA水平无差异。HIMG中VEGF-A和HIF-1α蛋白水平高于LIMG,两组均高于正常组;肿瘤边缘和中心的蛋白表达存在显著差异。相关性分析表明,关键miRNA(miR-20a和miR-20b)与靶蛋白(VEGF-A和HIF-1α)呈负相关。

结论

我们的数据表明,miR-20a和miR-20b在乳腺癌中分布存在差异,而VEGF-A和HIF-1α mRNA分布一致,VEGF-A和HIF-1α蛋白分布不均且与miRNA相反。看来转移异质性的一个最重要方面是miR-20a和miR-20b的差异分布及其对靶蛋白的调控。

相似文献

1
Differential distribution of miR-20a and miR-20b may underly metastatic heterogeneity of breast cancers.miR-20a和miR-20b的差异分布可能是乳腺癌转移异质性的基础。
Asian Pac J Cancer Prev. 2012;13(5):1901-6. doi: 10.7314/apjcp.2012.13.5.1901.
2
Effects of differential distribution of microvessel density, possibly regulated by miR-374a, on breast cancer prognosis.微血管密度差异分布(可能受miR - 374a调控)对乳腺癌预后的影响。
Asian Pac J Cancer Prev. 2013;14(3):1715-20. doi: 10.7314/apjcp.2013.14.3.1715.
3
miR-20b modulates VEGF expression by targeting HIF-1 alpha and STAT3 in MCF-7 breast cancer cells.miR-20b 通过靶向 MCF-7 乳腺癌细胞中的 HIF-1α和 STAT3 来调节 VEGF 的表达。
J Cell Physiol. 2010 Jul;224(1):242-9. doi: 10.1002/jcp.22126.
4
Clinicopathological Significance of MicroRNA-20b Expression in Hepatocellular Carcinoma and Regulation of HIF-1α and VEGF Effect on Cell Biological Behaviour.微小RNA-20b在肝细胞癌中的表达及其对缺氧诱导因子-1α和血管内皮生长因子的调控对细胞生物学行为的临床病理意义
Dis Markers. 2015;2015:325176. doi: 10.1155/2015/325176. Epub 2015 Nov 3.
5
MicroRNA-100 shuttled by mesenchymal stem cell-derived exosomes suppresses in vitro angiogenesis through modulating the mTOR/HIF-1α/VEGF signaling axis in breast cancer cells.间充质干细胞来源的外泌体携带 microRNA-100 通过调控乳腺癌细胞中的 mTOR/HIF-1α/VEGF 信号轴抑制体外血管生成。
Cell Oncol (Dordr). 2017 Oct;40(5):457-470. doi: 10.1007/s13402-017-0335-7. Epub 2017 Jul 24.
6
MicroRNA-20b Downregulates HIF-1α and Inhibits the Proliferation and Invasion of Osteosarcoma Cells.微小RNA-20b下调缺氧诱导因子-1α并抑制骨肉瘤细胞的增殖和侵袭
Oncol Res. 2016;23(5):257-66. doi: 10.3727/096504016X14562725373752.
7
Role of miRNA-210, miRNA-21 and miRNA-126 as diagnostic biomarkers in colorectal carcinoma: impact of HIF-1α-VEGF signaling pathway.miRNA-210、miRNA-21 和 miRNA-126 作为结直肠癌诊断生物标志物的作用:HIF-1α-VEGF 信号通路的影响。
Mol Cell Biochem. 2019 Apr;454(1-2):177-189. doi: 10.1007/s11010-018-3462-1. Epub 2018 Oct 24.
8
Expression of HIF-1α and Markers of Angiogenesis Are Not Significantly Different in Triple Negative Breast Cancer Compared to Other Breast Cancer Molecular Subtypes: Implications for Future Therapy.与其他乳腺癌分子亚型相比,三阴性乳腺癌中HIF-1α的表达和血管生成标志物无显著差异:对未来治疗的启示。
PLoS One. 2015 Jun 5;10(6):e0129356. doi: 10.1371/journal.pone.0129356. eCollection 2015.
9
Tumor biology of non-metastatic stages of clear cell renal cell carcinoma; overexpression of stearoyl desaturase-1, EPO/EPO-R system and hypoxia-related proteins.透明细胞肾细胞癌非转移阶段的肿瘤生物学;硬脂酰去饱和酶-1、促红细胞生成素/促红细胞生成素受体系统及缺氧相关蛋白的过表达
Tumour Biol. 2016 Oct;37(10):13581-13593. doi: 10.1007/s13277-016-5279-4. Epub 2016 Jul 28.
10
hsa-miR-210 Is induced by hypoxia and is an independent prognostic factor in breast cancer.人源微小RNA-210由缺氧诱导产生,是乳腺癌的一个独立预后因素。
Clin Cancer Res. 2008 Mar 1;14(5):1340-8. doi: 10.1158/1078-0432.CCR-07-1755.

引用本文的文献

1
Crosstalk between hypoxia-inducible factor (HIF) and lncRNAs in digestive tumors: from molecular mechanisms to clinical translation.缺氧诱导因子(HIF)与lncRNAs在消化系统肿瘤中的相互作用:从分子机制到临床转化
Front Cell Dev Biol. 2025 Aug 8;13:1611889. doi: 10.3389/fcell.2025.1611889. eCollection 2025.
2
Hypoxia-driven ncRNAs in breast cancer.乳腺癌中缺氧驱动的非编码RNA
Front Oncol. 2023 Jul 31;13:1207253. doi: 10.3389/fonc.2023.1207253. eCollection 2023.
3
The Intricate Interplay between Cancer Stem Cells and Oncogenic miRNAs in Breast Cancer Progression and Metastasis.
癌症干细胞与致癌性微小RNA在乳腺癌进展和转移中的复杂相互作用
Life (Basel). 2023 Jun 9;13(6):1361. doi: 10.3390/life13061361.
4
Effect of Silibinin on the Expression of Mir-20b, Bcl2L11, and Erbb2 in Breast Cancer Cell Lines.水飞蓟宾对乳腺癌细胞系中 Mir-20b、Bcl2L11 和 Erbb2 表达的影响。
Mol Biotechnol. 2023 Dec;65(12):1979-1990. doi: 10.1007/s12033-023-00702-5. Epub 2023 Mar 11.
5
MicroRNAs: Important Players in Breast Cancer Angiogenesis and Therapeutic Targets.微小RNA:乳腺癌血管生成中的重要参与者及治疗靶点
Front Mol Biosci. 2021 Oct 26;8:764025. doi: 10.3389/fmolb.2021.764025. eCollection 2021.
6
Intratumoral Heterogeneity of Expression of 16 miRNA in Luminal Cancer of the Mammary Gland.16种微小RNA在乳腺腔面癌中的肿瘤内表达异质性
Noncoding RNA. 2020 May 11;6(2):16. doi: 10.3390/ncrna6020016.
7
Micromanaging aerobic respiration and glycolysis in cancer cells.微调控癌细胞中的有氧呼吸和糖酵解。
Mol Metab. 2019 May;23:98-126. doi: 10.1016/j.molmet.2019.01.014. Epub 2019 Feb 6.
8
MiR-20a, a novel promising biomarker to predict prognosis in human cancer: a meta-analysis.miR-20a,一种有前途的新型人类癌症预后预测生物标志物:一项荟萃分析。
BMC Cancer. 2018 Nov 29;18(1):1189. doi: 10.1186/s12885-018-4907-3.
9
Reciprocal regulations between miRNAs and HIF-1α in human cancers.miRNAs 与 HIF-1α 在人类癌症中的相互调节作用。
Cell Mol Life Sci. 2019 Feb;76(3):453-471. doi: 10.1007/s00018-018-2941-6. Epub 2018 Oct 13.
10
Molecular mechanism of activated T cells in breast cancer.乳腺癌中活化T细胞的分子机制。
Onco Targets Ther. 2018 Aug 20;11:5015-5024. doi: 10.2147/OTT.S173018. eCollection 2018.